Citigroup Inc Essa Pharma Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$3.15 - $7.94 $2,390 - $6,026	-759 Reduced 55.89%	599 $2,000
Q1 2022 May 12, 2022	BUY	$6.18 - $14.44 $2,539 - $5,934	411 Added 43.4%	1,358 $8,000
Q4 2021 Feb 10, 2022	BUY	$7.8 - $14.38 $1,255 - $2,315	161 Added 20.48%	947 $13,000
Q3 2021 Nov 10, 2021	BUY	$7.76 - $29.37 $6,099 - $23,084	786 New	786 $6,000

31M

24.1K

15.1K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.8M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.